1549 studies found for:    Open Studies | "Lymphatic Diseases"
Show Display Options
Rank Status Study
21 Recruiting Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma
Condition: Lymphoma
Interventions: Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: fludarabine phosphate;   Drug: gemcitabine hydrochloride;   Drug: ifosfamide;   Drug: mechlorethamine hydrochloride;   Drug: melphalan;   Drug: methotrexate;   Drug: mycophenolate mofetil;   Drug: prednisone;   Drug: procarbazine hydrochloride;   Drug: vincristine sulfate;   Drug: vinorelbine tartrate;   Procedure: allogeneic bone marrow transplantation;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation;   Procedure: umbilical cord blood transplantation;   Radiation: total-body irradiation
22 Recruiting A Safety Study of SGN-CD19A for Leukemia and Lymphoma
Conditions: Burkitt Lymphoma;   Precursor B-cell Lymphoblastic Leukemia-Lymphoma
Intervention: Drug: SGN-CD19A
23 Recruiting Anti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or Lymphoma
Conditions: ALL;   B Cell Lymphoma;   Leukemia;   Large Cell Lymphoma;   Non-Hodgkin Lymphoma
Intervention: Biological: Anti-CD19- CAR
24 Recruiting Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies
Conditions: Leukemia, Acute Lymphocytic (ALL);   Leukemia, Myeloid, Acute(AML);   Leukemia, Myeloid, Chronic(CML);   Juvenile Myelomonocytic Leukemia (JMML);   Hemoglobinuria, Paroxysmal Nocturnal (PNH);   Hodgkin Lymphoma;   Lymphoma, Non-Hodgkin (NHL);   Myelodysplastic Syndrome (MDS)
Interventions: Device: CliniMACS;   Procedure: Stem cell transplantation;   Drug: Systemic chemotherapy and antibodies
25 Unknown  Zevalin With Non Myeloablative Allogeneic Stem Cell Transplantation in Patients With Non Hodgkin Lymphoma
Condition: Non-Hodgkins Lymphoma
Interventions: Drug: Rituximab;   Drug: 90Y ibritumomab tiuxetan (Zevalin);   Drug: Cyclophosphamide;   Drug: Fludarabine;   Other: Non myeloablative allogeneic stem cell transplantation
26 Recruiting Study of Rituximab and Brentuximab Vedotin for Relapsed Classical Hodgkin Lymphoma
Condition: Lymphoma
Intervention: Drug: Brentuximab vedotin & Rituximab
27 Recruiting A Randomised Evaluation of Molecular Guided Therapy for Diffuse Large B-cell Lymphoma With Bortezomib
Condition: Lymphoma, Large B-Cell, Diffuse
Interventions: Drug: Rituximab, cyclophosphamide, doxorubicin, vincristine, prednisolone;   Drug: Bortezomib, rituximab, cyclophosphamide, doxorubicin, vincristine, prednisolone
28 Not yet recruiting Compression Bandaging and Manual Lymph Drainage in Women With Lymphedema
Condition: Arm Lymphedema After Breast Cancer
Interventions: Other: Multimodal treatment: compression bandaging and manual lymph drainage.;   Other: Manual lymph drainage
29 Unknown  Breathing Adapted Radiotherapy for Mediastinal Lymphoma
Condition: Lymphoma
Intervention:
30 Recruiting Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma
Condition: Large B Cell Diffuse Lymphoma
Interventions: Drug: Rituximab;   Procedure: Prophylactic intrathecal chemotherapy
31 Not yet recruiting Chronic Granulomatous Disease Study in China
Condition: Granulomatous Disease, Chronic
Intervention:
32 Recruiting Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-intensity Conditioning for Relapsed Follicular Lymphoma
Conditions: Lymphoma, Follicular;   Stem Cell Transplantation
Intervention: Drug: Reduced_intensity conditioning
33 Unknown  Healthy Donor Study II - Comparing Plerixafor With G-CSF and Plerixafor
Condition: Malignant Lymphoma, Stem Cell Type
Interventions: Drug: Plerixafor (Mozobil);   Drug: Plerixafor + G-CSF
34 Recruiting Family Study of Lymphoproliferative Disorders
Conditions: Lymphoma, Non-Hodgkin;   Leukemia, Lymphocytic, Chronic, B-Cell;   Lymphoma, B-Cell;   Monoclonal B-Cell Lymphocytosis;   Multiple Myeloma
Intervention:
35 Recruiting Lenalidomide and Vaccine Therapy in Treating Patients With Early-Stage Asymptomatic Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: B-cell Chronic Lymphocytic Leukemia;   Contiguous Stage II Small Lymphocytic Lymphoma;   Noncontiguous Stage II Small Lymphocytic Lymphoma;   Stage 0 Chronic Lymphocytic Leukemia;   Stage I Chronic Lymphocytic Leukemia;   Stage I Small Lymphocytic Lymphoma;   Stage II Chronic Lymphocytic Leukemia
Interventions: Biological: pneumococcal polyvalent vaccine;   Drug: lenalidomide;   Other: pharmacological study;   Other: laboratory biomarker analysis
36 Recruiting Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma
Conditions: Contiguous Stage II Grade 1 Follicular Lymphoma;   Contiguous Stage II Grade 2 Follicular Lymphoma;   Contiguous Stage II Grade 3 Follicular Lymphoma;   Noncontiguous Stage II Grade 1 Follicular Lymphoma;   Noncontiguous Stage II Grade 2 Follicular Lymphoma;   Noncontiguous Stage II Grade 3 Follicular Lymphoma;   Stage I Grade 1 Follicular Lymphoma;   Stage I Grade 2 Follicular Lymphoma;   Stage I Grade 3 Follicular Lymphoma;   Stage III Grade 1 Follicular Lymphoma;   Stage III Grade 2 Follicular Lymphoma;   Stage III Grade 3 Follicular Lymphoma;   Stage IV Grade 1 Follicular Lymphoma;   Stage IV Grade 2 Follicular Lymphoma;   Stage IV Grade 3 Follicular Lymphoma
Interventions: Biological: ofatumumab;   Drug: bendamustine hydrochloride;   Drug: bortezomib;   Other: laboratory biomarker analysis;   Procedure: positron emission tomography with radiolabeled targeting agents;   Radiation: fludeoxyglucose F 18
37 Recruiting Clinical And Economic Impact Of Upfront Plerixafor In Autologous Transplantation
Conditions: Non-Hodgkin's Lymphoma;   Multiple Myeloma
Interventions: Drug: Plerixafor;   Drug: Filgrastim
38 Recruiting Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Conditions: Chemotherapeutic Agent Toxicity;   Cognitive/Functional Effects;   Lymphoma;   Neurotoxicity;   Radiation Toxicity
Interventions: Biological: rituximab;   Drug: cytarabine;   Drug: methotrexate;   Drug: procarbazine hydrochloride;   Drug: vincristine sulfate;   Radiation: whole-brain radiation therapy
39 Recruiting Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia
Conditions: Acute Lymphoblastic Leukemia;   Acute Myelogenous Leukemia;   Lymphoblastic Lymphoma;   Diffuse Large B-cell Lymphoma;   Burkitt Lymphoma/Leukemia
Interventions: Drug: Clofarabine;   Drug: Mitoxantrone
40 Recruiting Lymphocyte Reconstitution After Administration of Pegfilgrastim Versus Filgrastim After Peripheral Stem Cell Transplantation
Condition: Non Hodgkin Lymphoma
Interventions: Drug: Pegfilgrastim;   Drug: Filgrastim

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years